Is FMO3 p.Leu360Pro (c.1079T>C) pathogenic?

FMO3 p.Leu360Pro (c.1079T>C) is classified Likely benign in FMO3 (ClinVar, Single submitter, 2 submitters; last evaluated 2026-01-28). AlphaMissense: likely benign (0.0879); Rare (popmax 0.514%, afr); Associated with trimethylaminuria.

What condition is associated with FMO3 p.Leu360Pro (c.1079T>C)?

FMO3 p.Leu360Pro (c.1079T>C) is associated with trimethylaminuria (ClinVar).

How common is FMO3 p.Leu360Pro (c.1079T>C) in the general population?

FMO3 p.Leu360Pro (c.1079T>C) is rare (popmax 0.514%, afr) (gnomAD).

What do computational predictors say about FMO3 p.Leu360Pro (c.1079T>C)?

AlphaMissense predicts likely benign (score 0.0879) — an in-silico prediction, not a clinical call.

FMO3 p.Leu360Pro

c.1079T>C · rs28363581 · VCV21464

Likely benign Single submitter

Classification

Likely benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 2 submitters

AlphaMissense

likely benign

0.0879 · ACMG-weighted

gnomAD v4.1

Rare

rare (popmax 0.514%, afr)

Missense predictors

1/3 damaging

AlphaMissense, REVEL, SaProt

Conditions

trimethylaminuria

Computational evidence

Protein change
AlphaMissense	0.0879	likely benign
REVEL	0.03	moderately benign-leaning
SaProt	LLR -10.25	damaging
⇒ SaProt calls this damaging; AlphaMissense and REVEL do not.
Splicing
SpliceAI	<0.2	no splice effect predicted · four deltas, not one · how we know
Constraint at this position
Conservation	phyloP -2.8	GERP -3.5
Regional constraint	o/e 1.04	unconstrained · MANE · 25 kb · p 0.27 · regional, not allelic
Overall
CADD	3.454	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.514% African / African-American · 386/75,058 alleles

Filtering AF 0.472% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.455%

Overall 0.0278% 448/1,614,034 alleles · rare exomes 226/1,461,688 · genomes 222/152,346 · joint denominator

Ancestry group	Frequency	1 in
African / African-Americangrpmax	0.514%	194
Admixed American	0.055%	1,818
Remaining individualsnot grpmax-eligible	0.0432%	2,315
South Asian	0.0022%	45,545

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: FMO3
Protein: p.Leu360Pro
Coding: c.1079T>C
MANE Select: NM_001002294
dbSNP: rs28363581
Type: single nucleotide variant
Location: chr1:171114258 (GRCh38)
Gene constraint: LOEUF 1.314 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 95.50
Residue 360: a UniProt-annotated variant site (in)

Full FMO3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

trimethylaminuria — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

FMO3 c.484+2T>G Likely pathogenic ★★ same condition
FMO3 c.828-2A>G Likely pathogenic ★★ same condition
FMO3 p.Arg223Gln Likely pathogenic ★★ same condition
FMO3 p.Arg223Trp Likely pathogenic ★★ same condition
FMO3 p.Arg238Gln Pathogenic/Likely pathogenic ★★ same condition
FMO3 p.Arg238Ter Pathogenic/Likely pathogenic ★★ same condition
FMO3 p.Arg492Trp Pathogenic/Likely pathogenic ★★ same condition
FMO3 p.Arg500Ter Pathogenic/Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/fmo3-p-leu360pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown